Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7

1.

Deletion of CD137 Ligand Exacerbates Renal and Cutaneous but Alleviates Cerebral Manifestations in Lupus.

Mak A, Dharmadhikari B, Kow NY, Thamboo TP, Tang Q, Wong LW, Sajikumar S, Wong HY, Schwarz H.

Front Immunol. 2019 Jun 26;10:1411. doi: 10.3389/fimmu.2019.01411. eCollection 2019.

2.

Graphene Quantum Dots: Synthesis and Applications.

Kalluri A, Debnath D, Dharmadhikari B, Patra P.

Methods Enzymol. 2018;609:335-354. doi: 10.1016/bs.mie.2018.07.002. Epub 2018 Sep 7.

PMID:
30244796
3.

CD137L dendritic cells induce potent response against cancer-associated viruses and polarize human CD8+ T cells to Tc1 phenotype.

Dharmadhikari B, Nickles E, Harfuddin Z, Ishak NDB, Zeng Q, Bertoletti A, Schwarz H.

Cancer Immunol Immunother. 2018 Jun;67(6):893-905. doi: 10.1007/s00262-018-2144-x. Epub 2018 Mar 5.

PMID:
29508025
4.

Anti-CD137 Cancer Immunotherapy Suppresses Tumor Growth-Letter.

Dharmadhikari B, Zeng Q, Wu M, Schwarz H.

Cancer Res. 2018 Mar 15;78(6):1571. doi: 10.1158/0008-5472.CAN-17-2997. Epub 2018 Feb 28. No abstract available.

5.

Transcriptional and functional characterization of CD137L-dendritic cells identifies a novel dendritic cell phenotype.

Harfuddin Z, Dharmadhikari B, Wong SC, Duan K, Poidinger M, Kwajah S, Schwarz H.

Sci Rep. 2016 Jul 19;6:29712. doi: 10.1038/srep29712.

6.

Residue Specific and Chirality Dependent Interactions between Carbon Nanotubes and Flagellin.

Macwan IG, Zhao Z, Sobh OT, Mukerji I, Dharmadhikari B, Patra PK.

IEEE/ACM Trans Comput Biol Bioinform. 2016 May-Jun;13(3):541-8. doi: 10.1109/TCBB.2015.2459696.

PMID:
27295637
7.

CD137 and CD137L signals are main drivers of type 1, cell-mediated immune responses.

Dharmadhikari B, Wu M, Abdullah NS, Rajendran S, Ishak ND, Nickles E, Harfuddin Z, Schwarz H.

Oncoimmunology. 2015 Nov 11;5(4):e1113367. eCollection 2016 Apr. Review.

Supplemental Content

Loading ...
Support Center